May 22, 2017 – Testosterone Heart Attack Lawsuit Set To Begin Next Month
An MDL of over 6,500 pending testosterone lawsuits has been centralized in the Northern District of Illinois. All of the lawsuits have similar allegations against various drugmakers that they failed to warn consumers and the medical community of the possible increased risk of stroke, heart attacks, blood clots and more when taking their testosterone drugs. Androgel is the most popular of the testosterone therapies and therefore, all suits involving its use will be in the first set of trials for the bellwether cases. The first trial is scheduled to begin on June 5 and is expected to last 3 weeks. This suit indicates that the plaintiff suffered a heart attack about 2 months after beginning his Androgel prescription in May 2010.
ACR Price at posting:
25.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)